MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 3816252)

Published in Biol Psychiatry on November 08, 2008

Authors

Natalie Weder1, Bao Zhu Yang, Heather Douglas-Palumberi, Johari Massey, John H Krystal, Joel Gelernter, Joan Kaufman

Author Affiliations

1: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA.

Articles citing this

MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction. Biol Psychiatry (2013) 1.79

Neuroimaging of child abuse: a critical review. Front Hum Neurosci (2012) 1.75

Addiction science: Uncovering neurobiological complexity. Neuropharmacology (2013) 1.50

Gene-environment interaction in psychological traits and disorders. Annu Rev Clin Psychol (2011) 1.40

MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. Biol Psychiatry (2013) 1.22

Genetics of human aggressive behaviour. Hum Genet (2009) 1.20

Child abuse and epigenetic mechanisms of disease risk. Am J Prev Med (2013) 1.16

Research review: evaluating and reformulating the developmental taxonomic theory of antisocial behaviour. J Child Psychol Psychiatry (2013) 1.09

Early life adversity reduces stress reactivity and enhances impulsive behavior: implications for health behaviors. Int J Psychophysiol (2012) 1.09

The impact of childhood maltreatment: a review of neurobiological and genetic factors. Front Psychiatry (2011) 1.05

Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression. Psychopharmacology (Berl) (2010) 1.03

Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry (2013) 1.01

Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. Biol Psychiatry (2011) 1.01

Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev (2011) 1.00

Effects of child maltreatment and inherited liability on antisocial development: an official records study. J Am Acad Child Adolesc Psychiatry (2010) 1.00

Harsh discipline, childhood sexual assault, and MAOA genotype: an investigation of main and interactive effects on diverse clinical externalizing outcomes. Behav Genet (2010) 1.00

Understanding risk for psychopathology through imaging gene-environment interactions. Trends Cogn Sci (2011) 0.99

The effects of child maltreatment on early signs of antisocial behavior: genetic moderation by tryptophan hydroxylase, serotonin transporter, and monoamine oxidase A genes. Dev Psychopathol (2012) 0.98

Peripuberty stress leads to abnormal aggression, altered amygdala and orbitofrontal reactivity and increased prefrontal MAOA gene expression. Transl Psychiatry (2013) 0.94

Monoamine oxidase A regulates antisocial personality in whites with no history of physical abuse. Compr Psychiatry (2010) 0.92

Understanding Youth Antisocial Behavior Using Neuroscience through a Developmental Psychopathology Lens: Review, Integration, and Directions for Research. Dev Rev (2013) 0.92

Moderating role of the MAOA genotype in antisocial behaviour. Br J Psychiatry (2012) 0.91

MAOA-uVNTR and early physical discipline interact to influence delinquent behavior. J Child Psychol Psychiatry (2009) 0.91

Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. Psychiatr Genet (2009) 0.90

Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci (2012) 0.90

The role of the serotonergic system at the interface of aggression and suicide. Neuroscience (2013) 0.89

Emotional and behavioral sequelae of childhood maltreatment. Curr Opin Pediatr (2010) 0.88

MAOA alters the effects of heavy drinking and childhood physical abuse on risk for severe impulsive acts of violence among alcoholic violent offenders. Alcohol Clin Exp Res (2010) 0.88

Deviant peer affiliation and antisocial behavior: interaction with Monoamine Oxidase A (MAOA) genotype. J Abnorm Child Psychol (2011) 0.86

NMDARs mediate the role of monoamine oxidase A in pathological aggression. J Neurosci (2012) 0.86

Gene-environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study. J Child Psychol Psychiatry (2012) 0.85

MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.83

Resilience among women with HIV: Impact of silencing the self and socioeconomic factors. Sex Roles (2014) 0.79

The role of the monoamine oxidase A gene in moderating the response to adversity and associated antisocial behavior: a review. Psychol Res Behav Manag (2014) 0.78

Commentary: Childhood abuse: new insights into its association with posttraumatic stress, suicidal ideation, and aggression. J Pediatr Psychol (2010) 0.78

The interactive effect of MAOA-LPR genotype and childhood physical neglect on aggressive behaviors in Italian male prisoners. Genes Brain Behav (2014) 0.77

Impact of behavioral genetic evidence on the perceptions and dispositions of child abuse victims. Public Health Genomics (2014) 0.77

Underlying Mechanisms of Gene-Environment Interactions in Externalizing Behavior: A Systematic Review and Search for Theoretical Mechanisms. Clin Child Fam Psychol Rev (2015) 0.77

Cross-cultural gene- environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response: FKBP5 polymorphisms and childhood trauma in South Asia. Int Rev Psychiatry (2015) 0.77

Interactions Between Monoamine Oxidase A and Punitive Discipline in African American and Caucasian Men's Antisocial Behavior. Clin Psychol Sci (2014) 0.77

Child maltreatment, impulsivity, and antisocial behavior in African American children: Moderation effects from a cumulative dopaminergic gene index. Dev Psychopathol (2015) 0.76

The role of monoamine oxidase A in aggression: Current translational developments and future challenges. Prog Neuropsychopharmacol Biol Psychiatry (2016) 0.76

The inclination to evil and the punishment of crime - from the bible to behavioral genetics. Isr J Psychiatry Relat Sci (2014) 0.75

Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders. J Neurosci Res (2017) 0.75

Articles cited by this

Inference of population structure using multilocus genotype data. Genetics (2000) 147.76

Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics (2003) 53.11

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93

Role of genotype in the cycle of violence in maltreated children. Science (2002) 13.50

X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature (2005) 12.06

Mapping the functional connectivity of anterior cingulate cortex. Neuroimage (2007) 5.12

Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science (1993) 5.05

Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (1995) 4.59

Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42

MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry (2006) 4.16

Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97

Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry (1997) 3.79

A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 3.59

Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A (2006) 3.58

Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet (1997) 2.88

Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry (2004) 2.84

MAOA and the "cycle of violence:" childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. Biol Psychiatry (2006) 2.33

Understanding genetic risk for aggression: clues from the brain's response to social exclusion. Biol Psychiatry (2006) 2.17

Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol (2005) 2.09

Mapping the genetic variation of executive attention onto brain activity. Proc Natl Acad Sci U S A (2003) 2.09

Attention bias to threat in maltreated children: implications for vulnerability to stress-related psychopathology. Am J Psychiatry (2005) 2.08

Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98

Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry (2007) 1.88

Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. Am J Med Genet B Neuropsychiatr Genet (2005) 1.67

Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry (2005) 1.64

Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology (2007) 1.56

Meta-analysis of gene-environment interactions in developmental psychopathology. Dev Psychopathol (2007) 1.55

Interaction between MAO-A genotype and maltreatment in the risk for conduct disorder: failure to confirm in adolescent patients. Am J Psychiatry (2006) 1.49

An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology (2004) 1.49

Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS One (2007) 1.46

Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype. Biol Psychiatry (2006) 1.39

Depressive disorders in maltreated children. J Am Acad Child Adolesc Psychiatry (1991) 1.31

Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry (2002) 1.26

Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet (2007) 1.25

Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology (2005) 1.22

Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet (2005) 1.01

Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. Neuroimage (2007) 0.94

Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry (2007) 0.92

Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet (2004) 0.87

MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in indian children. Am J Med Genet B Neuropsychiatr Genet (2006) 0.86

Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet (2001) 0.84

Articles by these authors

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry (2004) 6.05

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46

Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42

Investment in HIV/AIDS programs: does it help strengthen health systems in developing countries? Global Health (2008) 4.10

Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97

National comorbidity survey replication adolescent supplement (NCS-A): III. Concordance of DSM-IV/CIDI diagnoses with clinical reassessments. J Am Acad Child Adolesc Psychiatry (2009) 3.92

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry (2004) 3.64

Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med (2011) 3.36

Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol (2008) 3.13

Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet (2004) 3.10

Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend (2005) 3.09

Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90

The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry (2007) 2.81

Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry (2011) 2.45

Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry (2009) 2.44

A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry (2010) 2.41

The role of default network deactivation in cognition and disease. Trends Cogn Sci (2012) 2.39

A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry (2003) 2.36

Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry (2005) 2.36

DCDC2 is associated with reading disability and modulates neuronal development in the brain. Proc Natl Acad Sci U S A (2005) 2.35

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res (2005) 2.35

Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend (2007) 2.26

Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry (2014) 2.18

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry (2008) 2.17

Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16

Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology (2010) 2.16

Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry (2003) 2.15

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia. J Clin Psychiatry (2012) 2.10

Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol (2005) 2.09

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry (2009) 2.09

Attention bias to threat in maltreated children: implications for vulnerability to stress-related psychopathology. Am J Psychiatry (2005) 2.08

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet (2003) 2.07

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2002) 2.01

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry (2002) 1.99

Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry (2009) 1.97

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry (2004) 1.96

Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96

Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet (2006) 1.93

Reaching and identifying the STD/HIV risk of sex workers in Beijing. AIDS Educ Prev (2002) 1.91

Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med (2005) 1.89

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86

CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet (2005) 1.85

Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am J Hum Genet (2006) 1.82

Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81

Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry (2003) 1.81

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res (2011) 1.80

Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry (2008) 1.76

Abnormal hemodynamics in schizophrenia during an auditory oddball task. Biol Psychiatry (2005) 1.72

Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology (2007) 1.71

Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry (2003) 1.70

Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology (Berl) (2005) 1.67

Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry (2012) 1.67

Rare ADH variant constellations are specific for alcohol dependence. Alcohol Alcohol (2012) 1.66

Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry (2006) 1.66

Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry (2003) 1.64

Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry (2004) 1.64

Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects. Am J Addict (2007) 1.63

Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res (2007) 1.62

Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry (2012) 1.62

A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits. Biol Psychiatry (2010) 1.62

Ketamine and the potential role for rapid-acting antidepressant medications. Swiss Med Wkly (2007) 1.62

Genetic and environmental predictors of early alcohol use. Biol Psychiatry (2006) 1.60

Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol (2009) 1.58

ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies. Pharmacogenet Genomics (2005) 1.58

Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology (2010) 1.58

Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet (2007) 1.55

Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol (2005) 1.55

Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry (2005) 1.55

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry (2005) 1.52

Glutamate metabolism in major depressive disorder. Am J Psychiatry (2014) 1.52

Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry (2006) 1.51

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull (2012) 1.50

Variant callers for next-generation sequencing data: a comparison study. PLoS One (2013) 1.50

Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. Neuropsychopharmacology (2011) 1.50

Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab (2002) 1.48

Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. Neuropsychopharmacology (2007) 1.48

Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry (2006) 1.47

Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder. Bipolar Disord (2005) 1.47

ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies. Neuropsychopharmacology (2006) 1.45

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx (2006) 1.43

Corpus callosum in maltreated children with posttraumatic stress disorder: a diffusion tensor imaging study. Psychiatry Res (2008) 1.42